First-in-Class Lupus Drug Aces Phase III Test

By News Health
3 months Ago

(MedPage Today) — BARCELONA — A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory systemic lupus erythematosus (SLE) get symptoms under control, according to phase III trial data…

Source link : https://www.medpagetoday.com/meetingcoverage/eular/116036

Author :

Publish date : 2025-06-12 16:13:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

More Definitive Evidence Carves Out LVEF Zone for Beta-Blockers After MI

It's About to Get Even Harder to Find a Doctor in Rural America

Texas Bill Would Let Residents Sue Out-of-State Abortion Pill Providers

Baby dies of whooping cough after mother not vaccinated while pregnant

County Durham mother's vaccination plea after 'terrifying' measles

Doctors Dismissed Her Symptoms for Years Before Lyme Disease Diagnosis